isatuximab

Spain

Drugs containing this active substance

  • SARCLISA 20 MG/ML CONCENTRATE FOR INFUSION SOLUTION

    It is used to treat multiple myeloma, a type of bone marrow cancer. It is administered along with other medications, depending on whether the patient has received previous treatments or if it is a recent diagnosis.

    Form: solution for infusion, concentrate

    Active substance Dosage
    isatuximab 20 mg

    ATC: L01F L01FC L01FC02

    Manufacturer: Sanofi Winthrop Industrie